Erbium
16
Mar

Overview

Erbium is a rare earth metal widely used as a dopant in fiber optic amplifiers and lasers for telecommunications.

Properties

It exhibits +3 oxidation state and provides emission at wavelengths ideal for optical communications around 1.5 ?m.

Occurrence and Uses

Key use as erbium doped fiber amplifiers EDFAs, in lasers, glass coloring and metallurgical applications.

Isotopes and Safety

Stable isotopes include Er 166 to Er 170; erbium compounds are of low acute toxicity and handled with routine precautions.

Chief Quality Officer (CQO)
16
Mar

Overview

The CQO establishes quality frameworks, measurement systems and improvement programs to reduce harm and elevate clinical outcomes and patient experience.

Program Leadership

They oversee accreditation readiness, safety reporting, root cause analysis and multidisciplinary improvement initiatives to sustain gains.

Data and Measurement

CQOs use dashboards, risk adjustment and outcome analytics to prioritize interventions and demonstrate value to stakeholders.

Background and Skills

CQOs typically have clinical backgrounds with training in quality methodologies and lead cross functional teams to embed continuous improvement into operations.

Copper
16
Mar

Overview

Copper is a reddish, ductile transition metal prized for excellent electrical and thermal conductivity and antimicrobial properties.

Properties

It forms stable +1 and +2 oxidation states, alloys readily bronze, brass and resists corrosion in many environments.

Occurrence and Uses

Copper is mined from sulfide and oxide ores and used in electrical wiring, electronics, plumbing, roofing and as an essential trace nutrient.

Isotopes and Safety

Stable isotopes Cu 63 and Cu 65 exist; copper is essential biologically but excessive exposure can cause toxicity and environmental concerns.

Infection Control Consumables
15
Mar

Overview

Infection control consumables reduce pathogen transmission and support safe turnover between patients.

Core items

Alcohol prep pads;Disinfectant wipes;Hand sanitizer;Surface disinfectant;Single use covers;Biohazard bags

Cleaning protocols

Follow manufacturer contact times use approved agents for equipment and surfaces and document cleaning

Supply placement

Locate hand hygiene stations at room entry and near patient table and stock single use items for rapid access

CT Enterography Protocol
15
Mar

Overview

CT enterography uses neutral oral contrast and multiphase acquisition to detect inflammation tumors and complications of the small bowel.

Acquisition Technique

Use thin collimation portal venous phase imaging with optional arterial phase for hypervascular lesions and enteric distension with neutral oral contrast.

Dose and Reconstruction

Apply dose modulation iterative reconstruction and thin slice multiplanar reformats for optimal lesion detection.

Clinical Use

Indicated for Crohn disease activity assessment tumor detection and acute complication evaluation such as perforation or obstruction.

CT Chest Pulmonary Embolism Protocol
15
Mar

Overview

CT pulmonary angiography requires precise contrast timing and thin slice acquisition to detect central and peripheral emboli.

Acquisition Parameters

Use high flow contrast injection bolus tracking at the pulmonary trunk and thin collimation with inspiratory breath hold.

Clinical Considerations

Assess right ventricular strain and ancillary findings such as infarction and pleural effusion to guide management.

Contrast and Renal Safety

Screen renal function and use low osmolar contrast protocols and hydration strategies for at risk patients.

Patient Lift and Transfer Aids
14
Mar

Overview

Transfer aids reduce staff injury risk and improve patient safety during transfers to and from the imaging table.

Types and Capacity

Provide ceiling lifts mobile lifts and bariatric transfer equipment rated for expected patient weights.

Training and Protocols

Train staff on safe transfer techniques use of equipment and team based lifts for complex cases.

Maintenance

Schedule inspections battery charging and load testing to ensure reliable operation when needed.

Medical Laboratory Scientist
13
Mar

Overview

Medical laboratory scientists run and validate assays in hematology, chemistry, microbiology and molecular diagnostics to produce reliable results for patient care.

Laboratory Practice

They perform specimen processing, instrument calibration, quality control and result verification and communicate critical values to clinical teams.

Quality and Compliance

MLS professionals maintain accreditation standards, participate in proficiency testing and troubleshoot analytical issues to ensure test accuracy and turnaround time.

Training and Certification

Medical laboratory scientists complete accredited programs, obtain certification and follow regulatory and safety standards with ongoing continuing education.

CT Abdomen Pelvis With Contrast Protocol
13
Mar

Overview

CT abdomen pelvis with contrast uses portal venous and arterial phases when indicated to evaluate solid organ injury tumors and vascular pathology.

Acquisition Phases

Include noncontrast when assessing stones or hemorrhage arterial phase for hypervascular lesions and portal venous phase for parenchymal evaluation.

Contrast Timing and Dose

Use bolus tracking and individualized contrast volume with dose reduction strategies and oral contrast when indicated for bowel evaluation.

Clinical Applications

Indicated for trauma staging oncologic staging infection and acute abdominal pain with protocol tailored to clinical question.

US Food and Drug Administration Medical X Ray and Device Regulation
13
Mar

Overview

FDA regulates safety and effectiveness of radiology devices including radiography CT MRI ultrasound and nuclear medicine systems through device classification and premarket review.

Modality Focus

Device specific guidance covers diagnostic x ray CT mammography MRI ultrasound and nuclear medicine imaging systems and contrast agents.

Key Programs

Includes device premarket pathways 510k and PMA guidance recognized consensus standards and postmarket surveillance.

Clinical Impact

Manufacturers and facilities rely on FDA guidance for device labeling performance claims and safety reporting.